Fact CheckerSign in

NCT02835313Completed

Promoting Recovery Optimization With WALKing Exercise After Stroke

Source: ClinicalTrials.gov · Last updated 28 Oct 2024

Brief summary (registry, in English)

Stroke survivors, as a group, are extremely inactive and this has serious consequences for them, including an increased risk of a second stroke and developing other diseases. This study investigates a novel intervention designed to improve everyday activity after stroke by combining walking training to improve walking capacity with a program to encourage more daily walking.

Status (registry)
Completed
Study type
Interventional
Enrollment
250 (actual)
First submitted
11 Jul 2016
Start date
18 Jul 2016
Primary completion date
31 Jan 2023
Lead sponsor
University of Delaware
Diseases
Stroke
NCT number
NCT02835313

What you commit to

  • Study type: Interventional
  • Participants enrolled: 250
  • From 18 Jul 2016 to the primary completion date, 31 Jan 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Current participation in physical therapy
  • Inability to walk outside the home prior to the stroke

Other illness

  • Evidence of cerebellar stroke
  • Other potentially disabling neurologic conditions in addition to stroke
  • Coronary artery bypass graft, stent placement or myocardial infarction within past 3 months
  • score \>1 on question 1b and \>0 on question 1c on the NIH Stroke Scale.

Other

  • Lower limb Botulinum toxin injection \<4 months earlier
  • Musculoskeletal pain that limits activity
  • Inability to communicate with investigators

Who the study is looking for

  • Age 21-85
  • Chronic stroke (\>6 months post stroke)
  • Able to walk at self-selected speed without assistance from another person (assistive devices are allowed)
  • Self-selected walking speed \>0.3 m/s and \<1.0 m/s
  • Average steps/day \<8,000
  • Resting heart rate between 40-100 beats per minute
  • Resting blood pressure between 90/60 to 170/90.

Age in the registry: 21 years to 85 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Delaware
Coordinator of this site? Confirm its status
NewarkUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.